vTv Therapeutics Inc.
General ticker "VTVT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $118.6M (TTM average)
vTv Therapeutics Inc. follows the US Stock Market performance with the rate: 40.1%.
Estimated limits based on current volatility of 2.7%: low 35.99$, high 38.02$
Factors to consider:
- Total employees count: 16 (+23.1%) as of 2023
- Top business risk factors: Need for additional capital, Regulatory and compliance, Clinical trial failures, Market competition, Litigation risks
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [17.74$, 56.06$]
- 2026-12-31 to 2027-12-31 estimated range: [8.95$, 31.35$]
Financial Metrics affecting the VTVT estimates:
- Negative: with PPE of -11.1 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -8.08 <= 0.07
- Negative: negative Industry operating cash flow (median)
- Positive: Investing cash flow per share per price, % of 0 > -0.65
- Positive: Return on assets ratio (scaled to [-100,100]) of 25.69 > 6.12
- Negative: negative Industry operating income (median)
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term VTVT quotes
Long-term VTVT plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $1.02MM | $0.00MM |
| Operating Expenses | $25.50MM | $25.20MM | $32.81MM |
| Operating Income | $-25.50MM | $-24.18MM | $-32.81MM |
| Non-Operating Income | $-0.46MM | $1.57MM | $1.73MM |
| Interest Expense | $0.01MM | $0.00MM | $0.01MM |
| R&D Expense | $13.60MM | $11.55MM | $17.86MM |
| Income(Loss) | $-25.97MM | $-22.61MM | $-31.08MM |
| Taxes | $0.00MM | $0.10MM | $-0.00MM |
| Profit(Loss)* | $-20.25MM | $-18.46MM | $-26.97MM |
| Stockholders Equity | $-24.68MM | $12.20MM | $64.44MM |
| Assets | $11.02MM | $38.27MM | $89.90MM |
| Operating Cash Flow | $-19.08MM | $-25.31MM | $-25.25MM |
| Investing Cash Flow | $4.40MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $12.00MM | $52.61MM | $77.44MM |
| Earnings Per Share** | $-9.71 | $-3.20 | $-3.20 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.